Prokidney Corp Stock Technical Analysis
| PROK Stock | USD 1.98 0.02 1.00% |
As of the 13th of February 2026, ProKidney Corp holds the Risk Adjusted Performance of (0.06), variance of 25.24, and Coefficient Of Variation of (1,132). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ProKidney Corp, as well as the relationship between them.
ProKidney Corp Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ProKidney, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ProKidneyProKidney | Build AI portfolio with ProKidney Stock |
ProKidney Corp Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 6.25 | Strong Buy | 7 | Odds |
Most ProKidney analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ProKidney stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ProKidney Corp, talking to its executives and customers, or listening to ProKidney conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. Anticipated expansion of ProKidney directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ProKidney Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate ProKidney Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating ProKidney Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause ProKidney Corp's market price to deviate significantly from intrinsic value.
It's important to distinguish between ProKidney Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProKidney Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, ProKidney Corp's market price signifies the transaction level at which participants voluntarily complete trades.
ProKidney Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ProKidney Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ProKidney Corp.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in ProKidney Corp on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding ProKidney Corp or generate 0.0% return on investment in ProKidney Corp over 90 days. ProKidney Corp is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates More
ProKidney Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ProKidney Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ProKidney Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 22.38 | |||
| Value At Risk | (8.95) | |||
| Potential Upside | 6.82 |
ProKidney Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProKidney Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ProKidney Corp's standard deviation. In reality, there are many statistical measures that can use ProKidney Corp historical prices to predict the future ProKidney Corp's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.89) | |||
| Treynor Ratio | (0.24) |
ProKidney Corp February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.23) | |||
| Mean Deviation | 3.82 | |||
| Coefficient Of Variation | (1,132) | |||
| Standard Deviation | 5.02 | |||
| Variance | 25.24 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.89) | |||
| Treynor Ratio | (0.24) | |||
| Maximum Drawdown | 22.38 | |||
| Value At Risk | (8.95) | |||
| Potential Upside | 6.82 | |||
| Skewness | (0.56) | |||
| Kurtosis | 0.3187 |
ProKidney Corp Backtested Returns
ProKidney Corp maintains Sharpe Ratio (i.e., Efficiency) of -0.0224, which implies the firm had a -0.0224 % return per unit of risk over the last 3 months. ProKidney Corp exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ProKidney Corp's Coefficient Of Variation of (1,132), risk adjusted performance of (0.06), and Variance of 25.24 to confirm the risk estimate we provide. The company holds a Beta of 1.92, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ProKidney Corp will likely underperform. At this point, ProKidney Corp has a negative expected return of -0.1%. Please make sure to check ProKidney Corp's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if ProKidney Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.54 |
Good reverse predictability
ProKidney Corp has good reverse predictability. Overlapping area represents the amount of predictability between ProKidney Corp time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ProKidney Corp price movement. The serial correlation of -0.54 indicates that about 54.0% of current ProKidney Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.54 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
ProKidney Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ProKidney Corp Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for ProKidney Corp across different markets.
About ProKidney Corp Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ProKidney Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ProKidney Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ProKidney Corp price pattern first instead of the macroeconomic environment surrounding ProKidney Corp. By analyzing ProKidney Corp's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ProKidney Corp's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ProKidney Corp specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Net Debt To EBITDA | 0.54 | 0.76 | Intangibles To Total Assets | 4.73E-4 | 4.49E-4 |
ProKidney Corp February 13, 2026 Technical Indicators
Most technical analysis of ProKidney help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ProKidney from various momentum indicators to cycle indicators. When you analyze ProKidney charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.23) | |||
| Mean Deviation | 3.82 | |||
| Coefficient Of Variation | (1,132) | |||
| Standard Deviation | 5.02 | |||
| Variance | 25.24 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.89) | |||
| Treynor Ratio | (0.24) | |||
| Maximum Drawdown | 22.38 | |||
| Value At Risk | (8.95) | |||
| Potential Upside | 6.82 | |||
| Skewness | (0.56) | |||
| Kurtosis | 0.3187 |
ProKidney Corp February 13, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ProKidney stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 28,097 | ||
| Daily Balance Of Power | (0.18) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 1.97 | ||
| Day Typical Price | 1.97 | ||
| Price Action Indicator | 0.01 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. Anticipated expansion of ProKidney directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ProKidney Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate ProKidney Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating ProKidney Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause ProKidney Corp's market price to deviate significantly from intrinsic value.
It's important to distinguish between ProKidney Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProKidney Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, ProKidney Corp's market price signifies the transaction level at which participants voluntarily complete trades.